• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型干粉吸入器的研制。

The development of a novel dry powder inhaler.

机构信息

Chemical and Biochemical Engineering, University of Western Ontario, 1151 Richmond Street, London N6A 5B9, Canada.

出版信息

Int J Pharm. 2012 Jul 15;431(1-2):45-52. doi: 10.1016/j.ijpharm.2012.04.019. Epub 2012 Apr 20.

DOI:10.1016/j.ijpharm.2012.04.019
PMID:22543053
Abstract

A novel active and multi-dose dry powder inhaler (DPI) was developed and evaluated to deliver a small quantity (100-500 μg) of pure drug without any excipient. This dry powder inhaler utilized two compressed air flows to dispense and deliver drug powder: the primary flow aerosolizes the drug powder from its pocket and the secondary flow further disperses the aerosol. In vitro tests by Anderson Cascade Impactor (ACI) indicated that the fine particle fraction (FPF) (<4.7 μm) of drug delivery could reach over a range of 50-70% (w/w). Emitted dose tests showed that delivery efficiency was above 85% and its relative standard deviation (RSD) was under 10%. Confocal microscopy was used to confirm the deposition of fluorescently labeled spray-dried powder in rabbit lungs. Also, a chromatographic method was used to quantify drug deposition. The results of animal tests showed that 57% of aerosol deposited in the rabbit lung and 24% deposited in its trachea. All the results implied that this novel active dry powder inhaler could efficiently deliver a small quantity of fine drug particles into the lung with quite high fine particle fraction.

摘要

一种新型主动多剂量干粉吸入器(DPI)被开发和评估,用于输送少量(100-500μg)无赋形剂的纯药物。这种干粉吸入器利用两股压缩空气流来分配和输送药物粉末:主气流将药物粉末从其口袋中雾化,次气流进一步分散气溶胶。安德森级联撞击器(ACI)的体外测试表明,药物输送的细颗粒分数(FPF)(<4.7μm)可达到 50-70%(w/w)的范围。发射剂量测试表明,输送效率超过 85%,其相对标准偏差(RSD)低于 10%。共聚焦显微镜用于确认荧光标记喷雾干燥粉末在兔肺中的沉积。此外,还使用了一种色谱方法来定量药物沉积。动物试验的结果表明,气溶胶有 57%沉积在兔子的肺部,24%沉积在气管中。所有结果表明,这种新型主动干粉吸入器可以有效地将少量的细药物颗粒输送到肺部,且具有相当高的细颗粒分数。

相似文献

1
The development of a novel dry powder inhaler.新型干粉吸入器的研制。
Int J Pharm. 2012 Jul 15;431(1-2):45-52. doi: 10.1016/j.ijpharm.2012.04.019. Epub 2012 Apr 20.
2
The clinical relevance of dry powder inhaler performance for drug delivery.干粉吸入器用于药物递送的性能的临床相关性。
Respir Med. 2014 Aug;108(8):1195-203. doi: 10.1016/j.rmed.2014.05.009. Epub 2014 May 24.
3
Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.干粉吸入剂中的空气分级器技术(ACT) 第4部分。Novolizer多剂量干粉吸入器中空气分级器技术的性能。
Int J Pharm. 2006 Mar 9;310(1-2):81-9. doi: 10.1016/j.ijpharm.2005.11.029. Epub 2006 Jan 25.
4
Novel dry powder inhalation system based on dispersion of lyophilisates.基于冻干制剂分散的新型干粉吸入系统。
Eur J Pharm Sci. 2011 May 18;43(1-2):32-40. doi: 10.1016/j.ejps.2011.03.005. Epub 2011 Mar 31.
5
In vitro tests for aerosol deposition. III: effect of inhaler insertion angle on aerosol deposition.体外气溶胶沉积测试。III:吸入器插入角度对气溶胶沉积的影响。
J Aerosol Med Pulm Drug Deliv. 2013 Jun;26(3):145-56. doi: 10.1089/jamp.2012.0989. Epub 2012 Oct 1.
6
Investigation of dry powder aerosolization mechanisms in different channel designs.不同通道设计下干粉气溶胶化机制的研究。
Int J Pharm. 2013 Nov 30;457(1):143-9. doi: 10.1016/j.ijpharm.2013.09.012. Epub 2013 Sep 18.
7
The Genuair® inhaler: a novel, multidose dry powder inhaler.健瑞儿®吸入器:一种新型多剂量干粉吸入器。
Int J Clin Pract. 2012 Mar;66(3):309-17. doi: 10.1111/j.1742-1241.2011.02832.x.
8
Development of an Inline Dry Powder Inhaler for Oral or Trans-Nasal Aerosol Administration to Children.开发一种用于儿童口服或经鼻气溶胶给药的在线干粉吸入器。
J Aerosol Med Pulm Drug Deliv. 2020 Apr;33(2):83-98. doi: 10.1089/jamp.2019.1540. Epub 2019 Aug 29.
9
Performance of Low Air Volume Dry Powder Inhalers (LV-DPI) when Aerosolizing Excipient Enhanced Growth (EEG) Surfactant Powder Formulations.低空气量干粉吸入器(LV-DPI)雾化辅料增强生长(EEG)表面活性剂粉末制剂时的性能。
AAPS PharmSciTech. 2021 Apr 15;22(4):135. doi: 10.1208/s12249-021-01998-9.
10
Pulmonary drug delivery by powder aerosols.粉末气溶胶肺部递药。
J Control Release. 2014 Nov 10;193:228-40. doi: 10.1016/j.jconrel.2014.04.055. Epub 2014 May 9.

引用本文的文献

1
Dry powder inhaler design and particle technology in enhancing Pulmonary drug deposition: challenges and future strategies.干粉吸入器设计和颗粒技术在增强肺部药物沉积中的作用:挑战与未来策略。
Daru. 2024 Dec;32(2):761-779. doi: 10.1007/s40199-024-00520-3. Epub 2024 Jun 11.
2
Nano-Formulations for Pulmonary Delivery: Past, Present, and Future Perspectives.肺部给药的纳米制剂:过去、现在与未来展望
Pharmaceutics. 2024 Jan 24;16(2):161. doi: 10.3390/pharmaceutics16020161.
3
The future of dry powder inhaled therapy: Promising or discouraging for systemic disorders?
干粉吸入疗法的未来:对全身疾病是有希望还是令人沮丧?
Int J Pharm. 2022 Feb 25;614:121457. doi: 10.1016/j.ijpharm.2022.121457. Epub 2022 Jan 10.
4
Development of an Innovative, Carrier-Based Dry Powder Inhalation Formulation Containing Spray-Dried Meloxicam Potassium to Improve the In Vitro and In Silico Aerodynamic Properties.开发一种创新的、基于载体的干粉吸入制剂,其包含喷雾干燥的美洛昔康钾,以改善体外和计算机模拟的空气动力学性质。
Pharmaceutics. 2020 Jun 10;12(6):535. doi: 10.3390/pharmaceutics12060535.
5
Development of Novel Chitosan Microcapsules for Pulmonary Delivery of Dapsone: Characterization, Aerosol Performance, and In Vivo Toxicity Evaluation.用于氨苯砜肺部递送的新型壳聚糖微胶囊的研制:表征、气溶胶性能及体内毒性评价
AAPS PharmSciTech. 2015 Oct;16(5):1033-40. doi: 10.1208/s12249-015-0283-3. Epub 2015 Feb 5.
6
Drug-targeting methodologies with applications: A review.具有应用的药物靶向方法:综述。
World J Clin Cases. 2014 Dec 16;2(12):742-56. doi: 10.12998/wjcc.v2.i12.742.
7
Advances in device and formulation technologies for pulmonary drug delivery.肺部药物递送的装置与制剂技术进展
AAPS PharmSciTech. 2014 Aug;15(4):882-97. doi: 10.1208/s12249-014-0114-y. Epub 2014 Apr 12.